Harvard Bioscience, Inc. (FRA:HBI)

Harvard Bioscience Revenue

Harvard Bioscience had revenue of $20.59M USD in the quarter ending September 30, 2025, a decrease of -6.28%. This brings the company's revenue in the last twelve months to $87.37M, down -10.60% year-over-year. In the year 2024, Harvard Bioscience had annual revenue of $94.14M, down -16.14%.

• Revenue (ttm): $87.37M
• Revenue Growth: -10.60%
• P/S Ratio: 0.39
• Revenue / Employee: $246.12K
• Employees: 355
• Market Cap: 29.35M EUR

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	94.14M	-18.12M	-16.14%
Dec 31, 2023	112.25M	-1.09M	-0.96%
Dec 31, 2022	113.34M	-5.57M	-4.68%
Dec 31, 2021	118.90M	16.80M	16.46%
Dec 31, 2020	102.10M	-14.08M	-12.12%
Dec 31, 2019	116.18M	-4.60M	-3.81%
Dec 31, 2018	120.77M	43.37M	56.02%
Dec 31, 2017	77.41M	-27.11M	-25.94%
Dec 31, 2016	104.52M	-4.14M	-3.81%
Dec 31, 2015	108.66M	1,000.00	-
Dec 31, 2014	108.66M	3.49M	3.32%
Dec 31, 2013	105.17M	-6.00M	-5.40%
Dec 31, 2012	111.17M	2.31M	2.12%
Dec 31, 2011	108.86M	685.00K	0.63%
Dec 31, 2010	108.18M	22.41M	26.12%
Dec 31, 2009	85.77M	-2.28M	-2.59%
Dec 31, 2008	88.05M	4.64M	5.57%
Dec 31, 2007	83.41M	7.23M	9.49%
Dec 31, 2006	76.18M	8.75M	12.98%
Dec 31, 2005	67.43M	-	-